{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05670730",
            "orgStudyIdInfo": {
                "id": "AOC 1044-CS1"
            },
            "organization": {
                "fullName": "Avidity Biosciences, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping",
            "officialTitle": "A Phase 1/2, Randomized, Placebo-controlled, Double-blind, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Single and Multiple Ascending Doses of AOC 1044 Administered Intravenously to Healthy Adult Volunteers and Participants With DMD Mutations Amenable to Exon 44 Skipping",
            "acronym": "EXPLORE44",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-aoc-in-healthy-adult-volunteers-and-participants-with-duchenne-muscular-dystrophy-dmd-mutations-amenable-to-exon-skipping"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-11-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-06",
            "studyFirstSubmitQcDate": "2023-01-02",
            "studyFirstPostDateStruct": {
                "date": "2023-01-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Avidity Biosciences, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "AOC 1044-CS1 (EXPLORE44) is a Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of single and multiple ascending doses of AOC 1044 in healthy adult volunteers and participants with DMD mutations amenable to exon 44 skipping.\n\nPart A is a single dose design with multiple cohorts (dose levels) in healthy adult volunteers.\n\nPart B is a multiple-ascending dose design with 3 cohorts (dose levels) in participants with Duchenne."
        },
        "conditionsModule": {
            "conditions": [
                "Duchenne Muscular Dystrophy",
                "Exon 44"
            ],
            "keywords": [
                "EXPLORE44",
                "Avidity Biosciences",
                "Avidity",
                "AOC 1044"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "AOC 1044-CS1 (EXPLORE44) is a 2-part study:\n\nPart A: 5 cohorts with single ascending doses conducted in healthy adult volunteers\n\nPart B: 3 cohorts with multiple ascending doses in participants with DMD mutations amenable to exon 44 skipping",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 64,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "AOC 1044-CS1 Part A - Single Dose Levels 1-5",
                    "type": "EXPERIMENTAL",
                    "description": "AOC 1044 will be administered once.",
                    "interventionNames": [
                        "Drug: AOC 1044"
                    ]
                },
                {
                    "label": "AOC 1044-CS1 Part A - Single Dose: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo will be administered once.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "AOC 1044-CS1 Part B - Multiple Ascending Dose Levels 1-3",
                    "type": "EXPERIMENTAL",
                    "description": "AOC 1044 will be administered three times.",
                    "interventionNames": [
                        "Drug: AOC 1044"
                    ]
                },
                {
                    "label": "AOC 1044-CS1 Part B - Multiple Ascending Dose: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo will be administered three times.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "AOC 1044",
                    "description": "AOC 1044 will be administered via intravenous (IV) infusion",
                    "armGroupLabels": [
                        "AOC 1044-CS1 Part A - Single Dose Levels 1-5",
                        "AOC 1044-CS1 Part B - Multiple Ascending Dose Levels 1-3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo will be administered via intravenous (IV) infusion.",
                    "armGroupLabels": [
                        "AOC 1044-CS1 Part A - Single Dose: Placebo",
                        "AOC 1044-CS1 Part B - Multiple Ascending Dose: Placebo"
                    ],
                    "otherNames": [
                        "Saline"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of treatment-emergent adverse events (TEAEs)",
                    "timeFrame": "Through study completion, up to Day 85 (Part A) or Day 169 (Part B)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma pharmacokinetic (PK) parameters",
                    "description": "Maximum plasma concentration (Cmax) of AOC 1044",
                    "timeFrame": "Through Week 8 (Part A); Through Week 12 (Part B)"
                },
                {
                    "measure": "Plasma pharmacokinetic (PK) parameters",
                    "description": "Terminal half-life (T1/2) of AOC 1044",
                    "timeFrame": "Through Week 8 (Part A); Through Week 12 (Part B)"
                },
                {
                    "measure": "Plasma pharmacokinetic (PK) parameters",
                    "description": "Area under the concentration-time curve (AUC) of AOC 1044",
                    "timeFrame": "Through Week 8 (Part A); Through Week 12 (Part B)"
                },
                {
                    "measure": "PMO44 levels in skeletal muscle tissue",
                    "timeFrame": "Through Week 4 (Part A); Through Week 16 (Part B)"
                },
                {
                    "measure": "Urine pharmacokinetic parameters",
                    "description": "Fraction of PMO44 excreted in urine",
                    "timeFrame": "Day 1-2 (0-24 hours after first dose) (Part A); Day 1-2 (0-24 hours after first dose) (Part B)"
                },
                {
                    "measure": "Change from baseline in exon skipping as measured in skeletal muscle (Part B only)",
                    "timeFrame": "Baseline, Week 16"
                },
                {
                    "measure": "Absolute change from baseline in dystrophin protein level in skeletal muscle (Part B only)",
                    "timeFrame": "Baseline, Week 16"
                },
                {
                    "measure": "Percentage change from baseline in dystrophin protein level in skeletal muscle (Part B only)",
                    "timeFrame": "Baseline, Week 16"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Part A:\n\nKey Inclusion Criteria:\n\n* Aged 18 to 55 years, inclusive, at the time of informed consent\n* Body mass index (BMI) of 18.5 to 32.0 kg/m2\n\nKey Exclusion Criteria:\n\n* Clinically significant abnormalities in laboratory results, ECGs, or vitals\n* Current or recent use of prescription or nonprescription drugs\n* Positive drug/alcohol test at Screening or Day -1\n* Elevated blood pressure (BP) \\>130/80 mmHg at Screening\n* Participation in a clinical study in which an investigational product was received within 1 month of screening or 5 half-lives of the investigational product\n* Blood or plasma donation within 16 weeks of planned AOC 1044 administration Note: Other protocol defined Inclusion/Exclusion criteria may apply\n\nPart B:\n\nKey Inclusion Criteria:\n\n* Aged 7 to 27 years, inclusive, at the time of informed consent\n* Clinical diagnosis of DMD or clear onset of DMD symptoms at or before the age of 6 years\n* Confirmation of DMD gene mutation amenable to exon 44 skipping\n* Weight \u2265 23 kg\n* Ambulatory or non-ambulatory\n\n  * Ambulatory participants: LVEF \u226550% and FVC\u226550%\n  * Non-ambulatory participants: LVEF \u226545% and FVC\u226540%\n* PUL 2.0 entry item A \u22653\n* If on corticosteroids, stable dose for 30 days before screening and throughout the study\n\nKey Exclusion Criteria:\n\n* Biceps brachii muscles unsuitable for biopsy\n* Serum hemoglobin \\< lower limit of normal\n* Uncontrolled hypertension or diabetes\n* Prior treatment with any cell or gene therapy\n* Prior treatment with another exon 44 skipping agent within 6 months prior to informed consent\n* Recently treated with an investigational drug\n* History of multiple drug allergies",
            "healthyVolunteers": true,
            "sex": "MALE",
            "minimumAge": "7 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Avidity Biosciences, Inc.",
                    "role": "CONTACT",
                    "phone": "858-771-7038",
                    "email": "medinfo@aviditybio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marc Morris, MD, JD, MS",
                    "affiliation": "Avidity Biosciences, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Arkansas Children's",
                    "status": "RECRUITING",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ashley Bryan",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "UCSD",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Parissa Shayesteh",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rabia Farooquee",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Rare Disease Research - Atlanta",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30329",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laura Sutton",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "University of Iowa",
                    "status": "RECRUITING",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laura Knosp",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "University of Massachusetts Chan Medical School",
                    "status": "RECRUITING",
                    "city": "Worcester",
                    "state": "Massachusetts",
                    "zip": "01655",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Figueira",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.26259,
                        "lon": -71.80229
                    }
                },
                {
                    "facility": "Gillette Children's",
                    "status": "RECRUITING",
                    "city": "Saint Paul",
                    "state": "Minnesota",
                    "zip": "55101",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Laura Feldman",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.94441,
                        "lon": -93.09327
                    }
                },
                {
                    "facility": "Rare Disease Research NC",
                    "status": "RECRUITING",
                    "city": "Hillsborough",
                    "state": "North Carolina",
                    "zip": "27278",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Annette Babu",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.07542,
                        "lon": -79.09973
                    }
                },
                {
                    "facility": "Abigail Research Institute at Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Regina Flomo",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Worldwide Clinical Trials (Part A only)",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78217",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000020388",
                    "term": "Muscular Dystrophy, Duchenne"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22185",
                    "name": "Muscular Dystrophy, Duchenne",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T698",
                    "name": "Becker Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1945",
                    "name": "Duchenne Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}